
29.00 Delayed Data As of Dec 08 | ![]() Today’s Change | 22.67 Today|||52-Week Range 47.48 | -16.88% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $2.7B |
Intellia Therapeutics, Inc. 40 Erie Street Cambridge Massachusetts 02139 |
John M. Leonard | President, Chief Executive Officer & Director |
Glenn Goddard | Chief Financial, Treasurer & Accounting Officer |
Laura Sepp-Lorenzino | Chief Scientific Officer & Executive VP |
David Lebwohl | Chief Medical Officer & Executive Vice President |
Eliana Clark | Chief Technology Officer & Executive VP |